QT Vascular to sell non-drug coated product to Medtronic for US$28m
QT Vascular said on Friday it has agreed to sell its non-drug coated Chocolate PTA to Medtronic for US$28 million.
The option agreement was inked on Thursday between the group and two subsidiaries and Medtronic Inc and one of its affiliates. The option is exercisable within 90 days upon achievement of certain milestones.
The group will convene an extraordinary general meeting to seek the approval of shareholders for the option agreement.
Pursuant to the option agreement, Medtronic has the option to acquire specific assets and license intellectual property relating to QT Vascular's non-drug coated Chocolate PTA Balloon Catheter product for use in the treatment, prevention, diagnosis or management of diseases in uncoated peripheral products.
QT Vascular said it will use the sales proceeds to pare down existing borrowings and liabilities, as well as to develop other products.
It currently has a five-year worldwide distribution agreement for Chocolate PTA with Medtronic that was entered into on Feb 2. This will be replaced with the business agreements following the closing of the sale, to facilitate the transfer of the assets.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance
Suntec Reit Q1 DPU down 13% to S$0.01511 in absence of capital distribution